<DOC>
	<DOCNO>NCT01938820</DOCNO>
	<brief_summary>Patients chronic hepatitis B histologically confirm early cirrhosis S4 ( similar metavir F4 , Ishak 5/6 ) randomly assign 1:1 ratio . One arm entecavir alone 2 year ; entecavir first 0.5 year , entecavir plus thymosin 1 year , entecavir another additional 0.5 year . Patients assessed baseline , every six month blood count , liver function test , HBVDNA , AFP , prothrombin time , liver ultrasonography , Fibroscan . The second liver biopsy perform evaluate regression rate liver fibrosis 1.5 year initial therapy .</brief_summary>
	<brief_title>Optimized Treatment Regression HBV-induced Early Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>1 . Patients age 18 65 year old ; 2 . Male female ; 3 . Treatmentnaive patient chronic hepatitis B histologically confirm early cirrhosis S4 ( similar metavir F4 , Ishak 5/6 ) consent undergo liver biopsy treatment ; 4 . Patients HBeAgpositive , HBVDNA &gt; 2×10 &lt; 3 &gt; IU/ml patient HBeAgnegative , HBVDNA &gt; 2×10 &lt; 2 &gt; IU/ml； 5 . Agree follow regularly ; 6 . Signature write informed consent . 1 . Patients decompensated cirrhosis : include ascites , hepatic encephalopathy , esophageal varix bleed complication decompensated cirrhosis hepatocelluar carcinoma ; 2 . Patients allergic entecavir , thymosin component , consider suitable drug use study ; 3 . Patients HCV HIV infection , alcoholic liver disease , autoimmune liver disease , genetic liver disease , druginduced liver injury , severe nonalcoholic fatty liver disease chronic liver disease ; 4 . Patients baseline AFP level high 100 ng/ml possible malignant lesion image , AFP level high 100 ng/ml three month ; 5 . Creatinine &gt; 1.5×ULN ; 6 . Patients uncured malignant tumor ; 7 . Patients severe disease heart , lung , kidney , brain , blood organ ; 8 . Patients reason suitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Liver Cirrhosis</keyword>
	<keyword>Regression</keyword>
	<keyword>Efficacy</keyword>
</DOC>